Reversible Hypopigmentation with Pazopanib

B. J. Srinivasa,Bhanu Prakash Lalkota, Pramod S. Chindar,Radheshyam Naik

Indian journal of medical and paediatric oncology（2018）

引用 0|浏览4

暂无评分

摘要

Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.

查看译文

关键词

Pazopanib,hypopigmentation,reversible,tyrosine kinase inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要